The Latest 

The FDA continues to allow products from these labs to be sold in the U.S. because it is often more concerned with supply than safety.

Chinese and Indian manufacturers receive the most FDA warning letters for violations of good manufacturing practices.

Other countries have made investments in API facilities; the U.S. is falling further behind.

The FDA recalled 28 different eye drop products sold over-the-counter in retail pharmacies like CVS and Target.

This summer ended with one recall after the next for Indian pharmaceutical companies that export generic drugs to the United States.

Aurobindo recalled 1,626 vials of Triamcinolone Acetonide Injectable Suspension, an important generic corticosteroid treatment.

The FDA is returning to a normal overseas inspection workload. What they are finding is not pretty.

The FDA approved Qilu Pharmaceuticals from Shandong, China, to sell the generic oncology drug cisplatin along with carboplatin.